This inventor holds 3 USPTO granted patents. Top assignees: Nycomed Imaging as, Amersham Health as. Active years: 2001-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2004
Title: Dagfinn Løvhaug: Innovator in Diagnostic and Therapeutic Agents
Introduction
Dagfinn Løvhaug is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of diagnostic and therapeutic agents, holding a total of three patents. His work focuses on enhancing the effectiveness of ultrasound contrast agents, which are crucial in medical imaging.
Latest Patents
Løvhaug's latest patents include innovative technologies such as targetable diagnostic and/or therapeutically active agents. One of his patents describes ultrasound contrast agents that comprise a suspension in an aqueous carrier liquid of a reporter made from gas-containing or gas-generating material. This agent is capable of forming at least two types of binding pairs with a target. Another patent focuses on targeted ultrasound contrast agents that utilize gas-filled microbubbles stabilized by monolayers of film-forming surfactants, with the reporter being coupled or linked to at least one vector.
Career Highlights
Throughout his career, Dagfinn Løvhaug has worked with prominent companies in the medical imaging sector, including Nycomed Imaging AS and Amersham Health AS. His expertise in the development of advanced diagnostic tools has positioned him as a key figure in the industry.
Collaborations
Løvhaug has collaborated with notable professionals in his field, including Jo Klaveness and Pål Rongved. These partnerships have contributed to the advancement of his innovative projects and patents.
Conclusion
Dagfinn Løvhaug's work in the field of diagnostic and therapeutic agents showcases his commitment to improving medical imaging technologies. His patents reflect a deep understanding of the complexities involved in creating effective ultrasound contrast agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
